https://iem1754inhibitor.com/a....-new-specialized-med
Although the medical application for automobile T cells is currently limited to some hematological malignancies, researchers are making an effort to develop CAR T cell-based therapies for the treatment of solid tumors. Nevertheless, while in the situation of CD19, or other objectives limited to the hematopoietic compartment, the toxicity is bound and manageable, the scarcity of particular antigens expressed by solid tumors rather than by healthier cells from essential organs helps mak
Like
Comment
Share
